Artículos por temáticas

Medication reconciliation role and value in Alzheimer's disease treatment

Shen X, Zhang Q, Shao W, Shi J, Liu B.

Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.

Nose-to-brain drug delivery for the treatment of Alzheimer's disease: current advancements and challenges

A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A.

Expert Opin Drug Deliv. 2022 Jan;19(1):87-102. doi: 10.1080/17425247.2022.2029845. Epub 2022 Jan 28.

Potential of flavonoids as anti-Alzheimer's agents: bench to bedside

Kaur R, Sood A, Lang DK, Bhatia S, Al-Harrasi A, Aleya L, Behl T.

Environ Sci Pollut Res Int. 2022 Apr;29(18):26063-26077. doi: 10.1007/s11356-021-18165-z. Epub 2022 Jan 24.

Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease

Pandey SN, Singh G, Semwal BC, Gupta G, Alharbi KS, Almalki WH, Albratty M, Najmi A, Meraya AM.

J Food Biochem. 2022 Dec;46(12):e14426. doi: 10.1111/jfbc.14426. Epub 2022 Sep 28.

Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19

Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM.

Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369.

Recent Advancements in CNS Acting Drugs: A Step Towards End of Illness

Javed MN, Pottoo FH, Naim MJ, Chawla PA.

CNS Neurol Disord Drug Targets. 2022;21(10):882-883. doi: 10.2174/187152732110220722112205.

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

Wang X, Wei S, Zhao C, Li X, Jin J, Shi X, Su Z, Li J, Wang J.

J Biol Inorg Chem. 2022 Aug;27(4-5):405-419. doi: 10.1007/s00775-022-01942-7. Epub 2022 Jun 17.

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam M, Shen F, Regmi D, Du D.

Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24.

Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology

Hassan NA, Alshamari AK, Hassan AA, Elharrif MG, Alhajri AM, Sattam M, Khattab RR.

Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Kumar B, Kumar N, Thakur A, Kumar V, Kumar R, Kumar V.

Curr Drug Targets. 2022;23(7):729-751. doi: 10.2174/1389450123666220117104038.

Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship

Li J, Sun M, Cui X, Li C.

Int J Mol Sci. 2022 Sep 2;23(17):10020. doi: 10.3390/ijms231710020.

Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review

Sánchez-de-Lara-Sánchez S, Sánchez-Pérez AM.

J Alzheimers Dis. 2022;89(4):1173-1191. doi: 10.3233/JAD-220615.

Deep brain stimulation of fornix for memory improvement in Alzheimer's disease: A critical review

Li R, Zhang C, Rao Y, Yuan TF.

Ageing Res Rev. 2022 Aug;79:101668. doi: 10.1016/j.arr.2022.101668. Epub 2022 Jun 12.

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

Targeted Delivery of Montelukast for the Treatment of Alzheimer's Disease

Datusalia AK, Singh G, Yadav N, Gaun S, Manik M, Singh RK.

CNS Neurol Disord Drug Targets. 2022;21(10):913-925. doi: 10.2174/1871527320666210902163756.